Literature DB >> 29717058

Exosomes and cardiovascular cell-cell communication.

Adam J Poe1, Anne A Knowlton2,3,4.   

Abstract

Exosomes have become an important player in intercellular signaling. These lipid microvesicles can stably transfer miRNA, protein, and other molecules between cells and circulate throughout the body. Exosomes are released by almost all cell types and are present in most if not all biological fluids. The biologically active cargo carried by exosomes can alter the phenotype of recipient cells. Exosomes increasingly are recognized as having an important role in the progression and treatment of cardiac disease states. Injured cardiac cells can release exosomes with important pathological effects on surrounding tissue, in addition to effecting other organs. But of equal interest is the possible benefit(s) conferred by exosomes released from stem cells for use in treatment and possible repair of cardiac damage.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  cardiovascular disease; cargo; exosomes; microvesicles; stem cells

Mesh:

Year:  2018        PMID: 29717058     DOI: 10.1042/EBC20170081

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  8 in total

Review 1.  Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications.

Authors:  Chaoshan Han; Junjie Yang; Jiacheng Sun; Gangjian Qin
Journal:  Pharmacol Ther       Date:  2021-10-20       Impact factor: 13.400

Review 2.  Cardiomyocyte-Derived Exosomes: Biological Functions and Potential Therapeutic Implications.

Authors:  Hui Yu; Zhanli Wang
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

3.  BMSC-Exosomes Carry Mutant HIF-1α for Improving Angiogenesis and Osteogenesis in Critical-Sized Calvarial Defects.

Authors:  Chenting Ying; Rui Wang; Zhenlin Wang; Jie Tao; Wenjing Yin; Jieyuan Zhang; Chengqing Yi; Xin Qi; Dan Han
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

4.  Mesenchymal stem cell-derived exosomal microRNA-182-5p alleviates myocardial ischemia/reperfusion injury by targeting GSDMD in mice.

Authors:  Rongchuan Yue; Shengzhong Lu; Yu Luo; Jing Zeng; Hao Liang; Dan Qin; Xiaobo Wang; Tao Wang; Jun Pu; Houxiang Hu
Journal:  Cell Death Discov       Date:  2022-04-14

5.  Expression Profiles and Functional Analysis of Plasma Exosomal Circular RNAs in Acute Myocardial Infarction.

Authors:  Guo-Dong He; Jie Li; Zhi-Qiang Nie; Shuo Sun; Ying-Qing Feng; Yu-Qing Huang
Journal:  Biomed Res Int       Date:  2022-10-01       Impact factor: 3.246

Review 6.  Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis.

Authors:  Roman Tikhomirov; Benedict Reilly-O' Donnell; Francesco Catapano; Giuseppe Faggian; Julia Gorelik; Fabio Martelli; Costanza Emanueli
Journal:  Cells       Date:  2020-03-02       Impact factor: 7.666

Review 7.  Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.

Authors:  Xiaoshan Liao; Xushan Yang; Hong Deng; Yuting Hao; Lianzhi Mao; Rongjun Zhang; Wenzhen Liao; Miaomiao Yuan
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31

8.  The Regulation of Exosome-Derived miRNA on Heterogeneity of Macrophages in Atherosclerotic Plaques.

Authors:  Ximing Li; Xinyong He; Junyan Wang; Dan Wang; Peiwei Cong; Aisong Zhu; Wenna Chen
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.